Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States

In the United States, bladder cancer will be diagnosed in an estimated 81,000 patients in 2018 [1]. Radical cystectomy (RC) with a thorough pelvic lymph node dissection is the treatment of choice for muscle-invasive bladder cancer [2,3]. Following RC, reconstruction of the urinary system can be performed using a variety of techniques. The critical distinction of different diversion options is between incontinent diversions (ID) and continent diversions (CD), such as catheterizable continent cutaneous pouches and the most common form, the orthotopic neobladder.

Source: Urologic Oncology: Seminars and Original Investigations - November 25, 2018 Category: Urology & Nephrology Authors: Michael Lin-Brande, Azadeh Nazemi, Shane M. Pearce, Eli R. Thompson, Akbar N. Ashrafi, Hooman Djaladat, Anne Schuckman, Siamak Daneshmand Tags: Original article Source Type: research